Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 8Recruiting 6Active not recruiting 4Unknown 3

Sponsor Class

OTHER 13NIH 8NETWORK 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Fallopian Tube Neoplasms 1Brenner Tumor 1

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × NETWORK × Watchful Waiting × Clear all
NCT05148728 2021-12-08

Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors

Vall Hebron Insitut Recerca

Phase NA Unknown
120 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00108745 2021-09-30

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

GOG Foundation

Phase 3 Unknown
1,157 enrolled 15 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

NCT01500512 2021-09-30

GROINSS-V

GOG Foundation

Unknown
148 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡